Table: q1_q4_2023_prescription_drug_wac_increases , manufacturer_name like Q*

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  *

oshpd_id	manufacturer_name	date_reported	ndc_number	drug_product_description	drug_category	drug_category_source	wac_effective_date	wac_increase_amount	wac_after_increase	patent_expiration_date	drug_source_type	unit_sales_volume_in_us	unit_sales_volume_non_public_indicator	cost_increase_factors	cost_increase_factors_non_public_indicator	change_improvement_description	change_improvement_non_public_indicator	acquisition_date	company_acquired_from	acquisition_price	acquisition_price_non_public_indicator	acquisition_price_comment	wac_at_acquisition	wac_year_prior_to_acquisition	year_drug_introduced_to_market	wac_at_intro_to_market	supporting_documents	general_comments
Rx0000462	QOL Medical LLC	03/31/2023	67871011101	Sacrosidase Solution 8500 Unit/ML, 118 ML, Bottle	Brand	FDA	01/01/2023	165.67	4309.36	None	Single Source Drug	None	1	None	1	None	1	None	None	None	None	None	None	None	None	None	None	None
Rx0000462	QOL Medical LLC	03/31/2023	67871011104	Sacrosidase Solution 8500 Unit/ML, 118 ML, Bottle Qty 2	Brand	FDA	01/01/2023	331.34	8618.72	None	Single Source Drug	None	1	None	1	None	1	None	None	None	None	None	None	None	None	None	None	None